Skip to main content
Timothy Call, MD, Oncology, Rochester, MN, Mayo Clinic Hospital - Rochester

TimothyGeorgeCallMD

Oncology Rochester, MN

Associate Professor, Internal Medicine, Mayo Medical School

Dr. Call is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Call's full profile

Already have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1989 - 1993
  • Gundersen Lutheran Medical Foundation
    Gundersen Lutheran Medical FoundationResidency, Internal Medicine, 1980 - 1983
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 1980

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 1981 - 2025
  • MN State Medical License
    MN State Medical License 1990 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical Centre  
    Sameer A Parikh, Tait D Shanafelt, Paul J Hampel, Jose F Leis, Neil E Kay, Wei Ding, Timothy G Call, Deborah Bowen, Eli Muchtar, British Journal of Haematology

Abstracts/Posters

  • A Randomized Phase 2 Study Comparing Acalabrutinib with or without Obinutuzumab in the Treatment of Early Stage High Risk Patients with Chronic Lymphocytic Leukemia (C...
    Timothy G. Call, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis
    Timothy G. Call, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Tumor Mutational Load and Germline Polygenic Risk Score Predicts Time-to-First Treatment in Chronic Lymphocytic Leukemia (CLL) and High-Count Monoclonal B Cell Lymphoc...
    Timothy G. Call, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Newer CLL Agents Require Specific Management Techniques
    Newer CLL Agents Require Specific Management TechniquesJune 27th, 2017

Professional Memberships

Hospital Affiliations